跳至主要内容
临床试验/JPRN-UMIN000011860
JPRN-UMIN000011860已完成2 期

Clinical study of Adjuvant chemotherapy with TS-1 for breast cancer - Clinical study of Adjuvant chemotherapy with TS-1 for breast cancer

Breastopia Namba Hospital0 个研究点目标入组 380 人开始时间: 2013年10月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
380

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Active double cancer 2) Bilateral (synchronous or asynchronous) breast cancer, inflammatory breast cancer 3) A history of previous treatment with oral 5-fluorouracil derivatives for 2 weeks or longer (Patients who received intravenous 5-fluorouracil can be enrolled.) 4) Serious diarrhea 5) Others, Serious complications 6) Pregnant women, nursing women, or women who want to become pregnant 7) Patients judged to be unsuitable for enrollment in the study by their physicians

研究者

发起方
Breastopia Namba Hospital

相似试验